The news that Canada is offering the wonder-drug Ozempic at a fraction of its American price comes as no surprise to those who have watched the United States devolve into a grotesque parody of a healthcare system. Bernardo Bárbaro’s America, land of the free market and home of the bankrupt diabetic, has once again proven that its medical-industrial complex is the real emperor with no clothes. Meanwhile, Canada, that quiet neighbour to the north, has decided to act like a civilised nation and sell a life-altering drug for a price that does not require a second mortgage.
Let us set the scene. Ozempic, originally developed for type 2 diabetes, has become the darling of the weight-loss revolution, transforming bodies and bank balances with equal ferocity. In the United States, a monthly supply costs somewhere between $900 and $1,300, depending on your insurance plan. That is not a price. That is a ransom. Canada, in a move that should surprise no one, has listed the drug at roughly $150 per month. The difference is not a rounding error. It is a moral chasm.
Now the British NHS, ever the cautious steward of the public purse, is reportedly evaluating the pricing impact. This is the sort of phrasing that makes my blood run cold. Evaluating. Impact. The bureaucrats will be sharpening their pencils, commissioning reports, and holding meetings that could have been an email. They will weigh the cost against the benefit, the pence against the years of life gained. All the while, the Canadian system will be quietly dispensing Ozempic to those who need it without the hysteria of a market that has forgotten its purpose.
But let us not pretend this is simply about a single drug. This is about the intellectual and spiritual decadence of the West. The United States has built a healthcare system that is the envy of no one except pharmaceutical executives and their shareholders. It is a system where the price of a drug is not determined by its value but by what the market will bear. And the market will bear anything when your life depends on it. It is extortion, plain and simple, dressed up in the language of innovation and free enterprise.
Canada, for all its flaws, has not yet abandoned the idea that healthcare is a public good. It has a single-payer system that negotiates prices with shovels not guns. The result is a price that reflects the actual cost of production plus a reasonable profit. This is not socialism. This is sanity. The NHS, which used to be the gold standard of socialised medicine, now finds itself in the awkward position of learning from a former colony how to handle pharmaceutical pricing with dignity.
The real issue, however, is not the price of Ozempic. It is the creeping Americanisation of British healthcare, a process that has been underway since the Thatcher revolution. We have privatised bits and pieces, allowed private insurance to muscle in, and watched our cherished NHS become a hybrid monster that satisfies no one. The Canadian model should serve as a reminder: it is possible to have a system that is both efficient and equitable. It requires political will and a collective commitment to the idea that healthcare is a right, not a luxury.
What will the NHS do? History suggests a fudge. They will negotiate some discount, pat themselves on the back, and promise to revisit the issue next year. The public will be left to wonder why they cannot get the same deal as a Canadian. And the American system will continue to metastasise, producing miracle drugs that are miracles only for those who can afford them.
This is the tragedy of our age. We have the tools to save lives, but we have lost the will to share them. Canada has shown us the way, not through revolution but through the simple act of saying no to greed. The NHS should take note. And while it is at it, perhaps it should also take a hard look at our own pricing structures, which have quietly become as opaque and unjust as anything in the United States.
We are, in the end, what we choose to pay for. If we choose to pay through the nose for drugs that cost pennies to make, we are choosing a future where health is a privilege. The Canadian model offers an alternative. It is not perfect, but it is better. And in a world of falling empires and rising barbarism, better is all we can hope for.
